SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals and Pharmaceuticals zooms on receiving patent from Government of India

24 Nov 2022 Evaluate

IOL Chemicals And Pharmaceuticals is currently trading at Rs. 350.70, up by 19.95 points or 6.03% from its previous closing of Rs. 330.75 on the BSE.

The scrip opened at Rs. 331.05 and has touched a high and low of Rs. 356.20 and Rs. 331.05 respectively. So far 24788 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 536.70 on 07-Apr-2022 and a 52 week low of Rs. 295.10 on 08-Mar-2022.

Last one week high and low of the scrip stood at Rs. 356.20 and Rs. 316.25 respectively. The current market cap of the company is Rs. 2079.35 crore.

The promoters holding in the company stood at 43.69%, while Institutions and Non-Institutions held 2.46% and 53.83% respectively.

IOL Chemicals and Pharmaceuticals has received patent for invention entitled an improved safe process for the preparation of Sartan Drugs of formula I from Controller of Patent, Indian Patent Office; Government of India.

Valsartan, Losartan, Irbesartan, Olmesartan, Candesartan and other Sartan drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.

IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers.

IOL Chem & Pharma Share Price

96.89 0.94 (0.98%)
07-May-2026 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1842.80
Dr. Reddys Lab 1309.95
Cipla 1374.15
Zydus Lifesciences 941.40
Lupin 2469.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×